[Phase 6] Prostate Cancer Standardized Diagnosis and Treatment Courses-Clinical Trials of Prostate Cancer

Explore the new world---standardized curriculum "Prostate Cancer Standardized Diagnosis and Treatment College" project is sponsored by the Beijing Medical Award Foundation, guided by the Chinese Anti-Cancer Association Urology and Andrology Reproductive Tumor Committee, and Yimaitong fully supports it.

Among them, the "Prostate Cancer Standardized Diagnosis and Treatment Course" aims to promote and promote the knowledge of standardized diagnosis and treatment of prostate cancer, and improve the academic level and professional skills in the field of prostate cancer across the country.

The sixth "Prostate Cancer Standardized Diagnosis and Treatment Course", the sixth period is the "Clinical Trials of Prostate Cancer" brought by Professor Wang Xuegang from the First Affiliated Hospital of Xiamen University: Click to watch the highlights video! Highlights video clinical trial refers to any systematic study of drugs in humans (patients or healthy volunteers) to confirm or reveal the effects, adverse reactions, and/or absorption, distribution, metabolism and excretion of test drugs.
The purpose is to determine the efficacy and safety of the trial drug.

The development of clinical trials has important value and significance for patients, medical care and even the entire society.

So, what are the basic principles and procedures of clinical trials? What is the current status of drug clinical trials in China? What are the challenges facing China's anti-cancer drug clinical trials? What are the characteristics of prostate cancer clinical trials in China? This issue of "Clinical Trials of Prostate Cancer" will focus on these topics in detailed discussion and sharing, aiming to promote clinical understanding of drug clinical trials and provide potential directions for drug development decisions.

To watch the full video, please